Program Benefits for Pharmaceutical Manufacturers

A PharmaPhonetics™ adherence and persistency program offers significant benefits for pharmaceutical makers. Our programs:

• Increase patient compliance, adherence (the percentage of doses that are taken as prescribed) and persistency (taking the medication over time, and refilling prescriptions)
• Influence the persistency curve and increase patient retention
• Increase revenue and top line growth
• Increase brand ROI and days on treatment
• Increase the brands share
• Create a patient relationship and patient brand preference
• Generate physician brand preference due to differentiation
• Create a competitive advantage. Patient compliance can be seen as part of the value proposition of a drug when comparing it to another drug in its class
• Improve reach and frequency, offering an alternative intervention vehicle with the potential to reach more patients or reach patients that are not being reached with other program vehicles
• Make your budget go farther
• Help meet the change in focus to patient retention and loyalty from patient acquisition
• Provide better patient outcomes by helping educate the patient about the importance of adhering to their treatment regimen
• Are turn key, and easy to deploy and implement
• Scaleable
• Complementary with existing programs
• Meet all privacy requirements.

Patient Benefits

In addition to creating better patient outcomes, our patient adherence programs are:

• Convenient. Interactions are over the telephone, at a time designated by the patient
• Quick, and easy. PharmaPhonetics process is quick and easy. It only takes a couple of minutes to register for a program and then take calls. Interactions are short, and taking part is a breeze.
• Patient-centric. In addition to our patient-focused user design, patients can control the intervention using self-directed speech, and control when they conduct the interaction. Actively engaging patients and providing them with increased control can improve adherence and persistency.
• Patient preferred. Elderly patients are primary consumers of chronic medications. Studies have shown their preferred channel of communication is the telephone.
• Accessible. Some people don't read materials, and others don't use Web sites or have Internet access. Providing interactions via any telephone helps meet the needs of these individuals.

If you're searching for a real solution to improve your Patient Acquisition Retention Index, a PharmaPhonetics Patient Adherence program is the answer. You'll be amazed at what we can do, cost effectively, and with a real focus on ROI.

To learn more visit our PharmaPhonetics Market Research solutions, PharmaPhonetics pages, Contact us, or telephone us at 585-248-9289.

©2010 VoicePort. All rights reserved. Privacy Statement